Table 7. Clinical trials with dual PI3K-mTOR inhibitors in head and neck cancer patients.
Compound | Combination | Phase | State | NCT number |
---|---|---|---|---|
PF-05212384 | PD-0332991 | 1 | Recruiting | NCT03065062 |
Paclitaxel, Carboplatin | 1 | Recruiting | NCT02069158 | |
SF1126 | / | 2 | Recruiting | NCT02644122 |
BEZ235 | / | 1 | Completed | NCT00620594 |
NCT: Number clinicaltrials.gov identifier.